drugset / Trial / NCT01601470

Evaluation of Drug-drug Interaction Between LCZ696 and Sildenafil in Subjects With Mild to Moderate Hypertension

NCT01601470

Phase 2 Completed 28 enrolled Novartis Pharmaceuticals
NaSingle-groupOpen-label

Summary

This study was conducted to investigate the potential for a pharmacokinetic drug-drug interaction in support of the co-administration of LCZ696 and sildenafil.

Timeline

Start
2012-09
Primary completion
2013-01
Completion
2013-01

Drugs

EvaluationDrugModalityDoseRoute
Subject LCZ696 Unknown 400 mg
Subject Sildenafil Unknown 50 mg

Indications